世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米のグルコースモニタリングデバイス市場の2030年までの予測 - 地域別分析 - タイプ別(持続グルコースモニタリングデバイス、自己グルコースモニタリングデバイス)、用途別(1型糖尿病、2型糖尿病)、検査タイプ別(指先検査、代替部位検査)、エンドユーザー別(医療現場、セルフ/ホームケア)


North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)

北米のグルコースモニタリング機器市場は、2022年の59億8,778万米ドルから2030年には144億9,058万米ドルに成長すると予測されている。2022年から2030年までの年平均成長率は11.6%と推定される。 グルコースモ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2023年12月4日 US$3,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
99 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

北米のグルコースモニタリング機器市場は、2022年の59億8,778万米ドルから2030年には144億9,058万米ドルに成長すると予測されている。2022年から2030年までの年平均成長率は11.6%と推定される。

グルコースモニタリングデバイスの急速な技術進歩が北米グルコースモニタリングデバイス市場に拍車をかける

先進技術を搭載した製品は、糖尿病治療においてより効果的な利点を提供する。糖尿病の有病率が世界的に増加するにつれて、より高度な製品を求める需要も加速している。そのため、研究者たちは長年にわたって研究活動を行い、その結果、製品の革新がもたらされている。インスリンを体内に投与する方法には、注射針、インスリンペン、インスリンポンプなどがある。インスリンポンプは、皮膚の下にカニューレで接続された小型のコンピュータ化された糖尿病管理装置で、ゆっくりと持続的にインスリンレベルを供給する。個人は、要求に応じてプログラムを制御することができる。最適な糖尿病管理は、正確なグルコースモニタリング装置にかかっている。グルコースモニタリングデバイスの進歩が進むにつれ、必要な血液量が少なくなり、精度も向上している。血糖測定器とグルコースモニタリングデバイス間のデータ転送能力も向上している。血糖モニタリング技術のますますの進歩により、精度が向上し、必要な血液量が少なくなり、血糖測定器とグルコースモニタリング機器間でデータを転送する能力も向上している。2022年6月、アボット社は1つのセンサーでグルコースとケトンレベルを連続的にモニターする新しいバイオウェアラブルを発表した。このように、技術的進歩と新製品の流入の増加が相まって、予測数年間の市場成長を促進すると予想される。

北米グルコースモニタリングデバイス市場概要

北米のグルコースモニタリングデバイス市場は、米国、カナダ、メキシコにセグメント化されている。この地域の市場成長は、糖尿病有病率の上昇、老年人口の増加が市場成長にプラスの影響を与える主な要因である。さらに、モニタリングデバイスの技術的進歩は、2022-2030年の市場全体の成長をさらに促進する。

北米のグルコースモニタリングデバイス市場の収益と2030年までの予測 (百万米ドル)

北米のグルコースモニタリングデバイス市場細分化

北米のグルコースモニタリングデバイス市場は、タイプ、アプリケーション、検査部位、エンドユーザー、および国にセグメント化されます。

タイプに基づいて、北米のグルコースモニタリングデバイス市場は、連続グルコースモニタリングデバイスと自己グルコースモニタリングデバイスにセグメント化されます。2022年の北米グルコースモニタリングデバイス市場では、自己グルコースモニタリングデバイスセグメントが大きなシェアを占めている。

アプリケーションに基づいて、北米のグルコースモニタリングデバイス市場は、1型糖尿病と2型糖尿病にセグメント化される。2022年の北米グルコースモニタリングデバイス市場では、2型糖尿病セグメントが大きなシェアを占めている。

検査部位に基づき、北米のグルコースモニタリングデバイス市場は指先検査と代替部位検査に区分される。指先検査セグメントが2022年の北米グルコースモニタリングデバイス市場でより大きなシェアを占めた。

エンドユーザーに基づいて、北米のグルコースモニタリングデバイス市場は医療環境とセルフ/ホームケアにセグメント化される。セルフ/ホームケア分野が2022年の北米グルコースモニタリングデバイス市場でより大きなシェアを占めた。

国に基づいて、北米グルコースモニタリングデバイス市場は、米国、カナダ、メキシコにセグメント化される。2022年の北米グルコースモニタリングデバイス市場は米国が支配的であった。

B.Braun SE、F. Hoffmann-La Roche Ltd、LifeScan Inc、Medtronic Plc、Abbott Laboratories、Ypsomed Holding AG、Senseonics Holdings Inc、Nipro Corp、GE HealthCare Technologies Inc、Terumo Corpは、北米のグルコースモニタリング機器市場で事業を展開している主要企業の一部である。

ページTOPに戻る


目次

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Glucose Monitoring Devices Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Incidence of Diabetes
4.1.2 Growing Geriatric Population
4.1.3 Increasing Prevalence of Obesity
4.2 Key Market Restraints
4.2.1 High Cost of Glucose Monitoring Devices
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism in Developing Countries
4.4 Future Trends
4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices
5. Glucose Monitoring Devices Market - North America Market Analysis
5.1 North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 – 2030
6. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Type
6.1 Overview
6.2 North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Continuous Glucose Monitoring Devices
6.3.1 Overview
6.3.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Sensors
6.3.2.1.1 Sensors: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Transmitters
6.3.2.2.1 Transmitters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Receivers
6.3.2.3.1 Receivers: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Self-Glucose Monitoring Devices
6.4.1 Overview
6.4.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Testing Strips
6.4.2.1.1 Testing Strips: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.2 Glucose Meters
6.4.2.2.1 Glucose Meters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.3 Lancets
6.4.2.3.1 Lancets: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.4 Others
6.4.2.4.1 Others: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Type 1 Diabetes
7.3.1 Overview
7.3.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Type 2 Diabetes
7.4.1 Overview
7.4.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Testing Site
8.1 Overview
8.2 North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
8.3 Fingertip Testing
8.3.1 Overview
8.3.2 Fingertip Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alternate Site Testing
8.4.1 Overview
8.4.2 Alternate Site Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Healthcare Settings
9.3.1 Overview
9.3.2 Healthcare Settings: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Self/Homecare
9.4.1 Overview
9.4.2 Self/Homecare: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 –Country Analysis
10.1 North America: Glucose Monitoring Devices Market
10.1.1 Overview
10.1.2 North America: Glucose Monitoring Devices Market , by Country
10.1.2.1 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: North America Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.1.3.1 US: North America Glucose Monitoring Devices Market , by Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.3.2 US: North America Glucose Monitoring Devices Market , by Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.4 US: North America Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.1.5 US: North America Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.1.6 US: North America Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.2.3.1 Canada Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.3.2 Canada Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.4 Canada Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.2.5 Canada Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.2.6 Canada Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.3.3.1 Mexico Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.3.2 Mexico Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.3.6 Mexico Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America North America Glucose Monitoring Devices Market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 B. Braun SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 LifeScan Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medtronic Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Ypsomed Holding AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Senseonics Holdings Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nipro Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GE HealthCare Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Terumo Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

 

ページTOPに戻る


 

Summary

The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It is estimated to grow at a CAGR of 11.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel North America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

North America Glucose Monitoring Devices Market Overview

The North America North America glucose monitoring devices market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising diabetic prevalence, and increasing geriatric population are main factors positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030.

North America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Glucose Monitoring Devices Market Segmentation

The North America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the North America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on application, the North America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on testing site, the North America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on end user, the North America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on country, the North America glucose monitoring devices market is segmented int o the US, Canada, and Mexico. The US dominated the North America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, and GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the North America glucose monitoring devices market.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Glucose Monitoring Devices Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Incidence of Diabetes
4.1.2 Growing Geriatric Population
4.1.3 Increasing Prevalence of Obesity
4.2 Key Market Restraints
4.2.1 High Cost of Glucose Monitoring Devices
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism in Developing Countries
4.4 Future Trends
4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices
5. Glucose Monitoring Devices Market - North America Market Analysis
5.1 North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 – 2030
6. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Type
6.1 Overview
6.2 North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Continuous Glucose Monitoring Devices
6.3.1 Overview
6.3.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Sensors
6.3.2.1.1 Sensors: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Transmitters
6.3.2.2.1 Transmitters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Receivers
6.3.2.3.1 Receivers: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Self-Glucose Monitoring Devices
6.4.1 Overview
6.4.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Testing Strips
6.4.2.1.1 Testing Strips: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.2 Glucose Meters
6.4.2.2.1 Glucose Meters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.3 Lancets
6.4.2.3.1 Lancets: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.4 Others
6.4.2.4.1 Others: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Type 1 Diabetes
7.3.1 Overview
7.3.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Type 2 Diabetes
7.4.1 Overview
7.4.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Testing Site
8.1 Overview
8.2 North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
8.3 Fingertip Testing
8.3.1 Overview
8.3.2 Fingertip Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alternate Site Testing
8.4.1 Overview
8.4.2 Alternate Site Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Healthcare Settings
9.3.1 Overview
9.3.2 Healthcare Settings: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Self/Homecare
9.4.1 Overview
9.4.2 Self/Homecare: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 –Country Analysis
10.1 North America: Glucose Monitoring Devices Market
10.1.1 Overview
10.1.2 North America: Glucose Monitoring Devices Market , by Country
10.1.2.1 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: North America Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.1.3.1 US: North America Glucose Monitoring Devices Market , by Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.3.2 US: North America Glucose Monitoring Devices Market , by Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.4 US: North America Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.1.5 US: North America Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.1.6 US: North America Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.2.3.1 Canada Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.3.2 Canada Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.4 Canada Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.2.5 Canada Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.2.6 Canada Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.3.3.1 Mexico Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.3.2 Mexico Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.3.6 Mexico Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America North America Glucose Monitoring Devices Market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 B. Braun SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 LifeScan Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medtronic Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Ypsomed Holding AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Senseonics Holdings Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nipro Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GE HealthCare Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Terumo Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る